• Latest Posts

Gene & cell therapy manufacturer Ascend launches with more than $130M

LIfT BioSciences says data show potent killing of pancreatic cancer tumoroids

Cabaletta Bio’s lupus drug cleared for trial

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

ADVERTISEMENT

LIfT BioSciences hails breakthrough data for treating solid tumors

Interview 8 Mar 2023

Phacilitate’s Women in Advanced Therapies program supports women in science

Porton and DanausGT look to boost development of gene and cell therapy

Syena created to deliver first-in-class TCR-NK cell therapy

ADVERTISEMENT